Yew Bio Pharm Balance Sheet - Annual (OTCBB:YEWB)

Add to My Stocks
$0.37 $0 (0%) YEWB stock closing price Apr 24, 2018 (Closing)

The Yew Bio Pharm balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Yew Bio Pharm stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Yew Bio Pharm revenue Yew Bio Pharm operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Yew Bio Pharm balance sheet for 2016 shows cash on hand of $-. The company has a debt to equity ratio of 0.15.

View latest 10 year balance sheet data to check Yew Bio Pharm financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011
Cash---1.15M--
Marketable Securities------
Receivables23.06M11.04M1.26M-1M-
Inventory10.29M4.66M1.44M1.08M--
Raw Materials5.06M3.33M1.44M---
Work In Progress------
Finished Goods5.24M1.33M----
Notes Receivable------
Other Current Assets------
Total Current Assets
33.79M16.86M3.21M3.08M2.44M1.44M
Property Plant & Equipment1.77M1.74M1.89M2.01M1.66M1.39M
Accumulated Depreciation1.08M1.04M1.03M---
Net Property Plant & Equipment
---1.03M-15.95M
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles4.55M13.9M20.3M20.95M15.32M-
Deposits & Other Assets7.15M12.33M10.66M10.24M9.38M7.5M
Total Assets
46.19M43.81M35.04M35.31M28.04M24.9M
Notes Payable1.15M-----
Accounts Payable3.33M----1.36M
Current Portion Long-Term Debt2.6M3.84M-4.85M--
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities------
Total Current Liabilities
7.49M4.64M-4.99M-2.69M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
7.61M4.64M-4.99M-2.69M
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus9.65M9.62M8.55M8.05M10.39M7.2M
Retained Earnings27.07M25.06M20.44M16.66M13.18M11.46M
Treasury Stock------
Other Liabilities1.79M4.42M5.84M5.54M4.16M3.48M
Shareholders Equity38.57M39.17M34.9M30.31M27.78M22.2M
Total Liabilities & Shareholders Equity46.19M43.81M35.04M35.31M28.04M24.9M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The latest Yew Bio Pharm stock price, and Yew Bio Pharm historical stock prices show the stock price movement over time, and the Yew Bio Pharm PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Yew Bio Pharm owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for YEWB stock as of 2016 is $46.19M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Yew Bio Pharm for the year 2016 total to $7.61M. Liabilities for a company like Yew Bio Pharm include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
4.79
Debt to equity ratio
0.15
Asset turnover ratio
0.39
Receivables turnover
1.48
Price to book ratio
0.45